|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Stock-based compensation expense | |||||
| Gain on retirement of royalty accrual | |||||
| Debt discount amortization | |||||
| Depreciation | |||||
| Foreign exchange differences | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables and prepaid expenses | |||||
| Accounts payable | |||||
| Accrued expenses and other payables | |||||
| Founders claim accrual | |||||
| Accrued royalties | |||||
| Registration Rights Agreement liability | |||||
| Accrued severance | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash acquired in reverse recapitalization | |||||
| Purchase of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Issuance costs | |||||
| Proceeds from convertible promissory notes, net | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net decrease in cash | |||||
| Cash, beginning of year | |||||
| Cash, end of year | |||||
| Shares issued at reverse recapitalization | |||||
| Net liabilities assumed in reverse recapitalization | |||||
| Return of founders shares to the Company as part of claim settlement | |||||
| Settlement of Treasury Stock prior to recapitalization | |||||
Loading...